首页> 中文期刊> 《综合精神医学》 >Nicotine dependence in community-dwelling Chinese patients with schizophrenia

Nicotine dependence in community-dwelling Chinese patients with schizophrenia

         

摘要

Background Smoking is a serious public health problem. Patients with schizophrenia usually have a higher prevalence of smoking than the general population, but the level of nicotine dependence is seldom studied, especially for patients living in the communities. Aims This study aimed to examine the level of nicotine dependence in Chinese community-dwelling patients with schizophrenia and explored its associated sociodemographic and clinical factors. Methods A total of 621 patients with schizophrenia treated in the primary care centres of Guangzhou were consecutively recruited. The level of nicotine dependence was assessed with the Chinese version of the Fagerstrom Test for Nicotine Dependence (FTND). Results 148 patients with schizophrenia were current smokers, and the mean (SD) score of FTND was 5.06 (2.55) for all the current smokers. The prevalence of nicotine addiction was 48.0%(95% Cl: 40.0%-56.0%) in patients with current smoking. The patients with schizophrenia had a significantly higher level of nicotine dependence than the Chinese general population. Multiple linear regression analysis revealed that male gender, being unemployed, having a family history of psychiatric disorders, having major medical conditions, first illness episode and less severe positive symptoms were significantly associated with a higher level of nicotine dependence. Conclusion Community-dwelling patients with schizophrenia in China, especially male patients, had a higher level of nicotine dependence than the general population.

著录项

  • 来源
    《综合精神医学》 |2019年第1期|26-31|共6页
  • 作者单位

    The National Clinical Research Center for Mental Disorders & Beijing Key Laboratory of Mental Disorders Beijing Anding Hospital & the Advanced Innovation Center for Human Brain Protection Capital Medical University School of Mental Health Beijing China;

    Unit of Psychiatry Institute of Translational Medicine Faculty of Health Sciences University of Macau Macao SAR China;

    Guangdong Mental Health Center Guangdong General Hospital and Guangdong Academy of Medical Sciences Guangzhou China;

    Ningxia Mental Health Center Ningxia Ning-An Hospital Ningxia China;

    Shenzhen Key Laboratory for Psychological Healthcare Shenzhen Institute of Mental Health Shenzhen Kangning Hospital & Shenzhen Mental Health Center Shenzhen China;

    Guangdong Mental Health Center Guangdong General Hospital and Guangdong Academy of Medical Sciences Guangzhou China;

    Department of Psychiatry The Chinese University of Hong Kong Hong Kong China;

    The University of Notre Dame Australia/Marian Centre Perth Australia;

    Department of Psychiatry University of Melbourne Melbourne Victoria Australia;

    Guangzhou Yuexiu Center for Disease Control and Prevention Guangdong China;

  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

相似文献

  • 中文文献
  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号